Literature DB >> 108462

Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism.

J H Hengstmann, R Gugler, H J Dengler.   

Abstract

In a patient with malignant pheochromocytoma treated unsuccessfully with propranolol and phenoxybenzamine the additional therapy with alpha-methyl-p-tyrosine resulted in a substantial decrease of the blood pressure to almost normal values. His general condition improved considerably. During therapy the urinary excretion rates of catecholamines and all their metabolites dropped to about 50% of control values. O-Hydroxylation of alpha-methyl-p-tyrosine could be demonstrated by the isolation of alpha-methyldopa and alpha-methylnormetanephrine. After discontinuation of treatment with alpha-methyl-p-tyrosine blood pressure and catecholamines returned to control values within two days.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 108462     DOI: 10.1007/bf01476565

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Determination of urine dopamine.

Authors:  F BISCHOFF; A TORRES
Journal:  Clin Chem       Date:  1962-08       Impact factor: 8.327

2.  The rôle of amine oxidase in the inactivation of catechol amines injected in man.

Authors:  U S VON EULER; B T ZETTERSTROM
Journal:  Acta Physiol Scand Suppl       Date:  1955

3.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

4.  Alpha-methyl-p-tyrosine in the management of phaeochromocytoma.

Authors:  N F Jones; G Walker; C R Ruthven; M Sandler
Journal:  Lancet       Date:  1968-11-23       Impact factor: 79.321

5.  [Purification and characterization of human placenta S-adenosylmethionine:catechol-O-methyltransferase].

Authors:  R Gugler; R Knuppen; H Breuer
Journal:  Biochim Biophys Acta       Date:  1970-10-14

6.  Catecholamines and the circulatory system. Pheochromocytoma.

Authors:  J R Crout
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Uptake, storage and release of H3-alpha-methyl norepinephrine.

Authors:  A Carlsson; P Lundborg; R Stitzel; B Waldeck
Journal:  J Pharmacol Exp Ther       Date:  1967-11       Impact factor: 4.030

8.  Evidence for extratumoural storage of catecholamines in pheochromocytoma patients.

Authors:  J H Hengstmann; H J Dengler
Journal:  Acta Endocrinol (Copenh)       Date:  1978-03

9.  Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.

Authors:  H K Brodie; D L Murphy; F K Goodwin; W E Bunney
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

10.  The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.

Authors:  T L Sato
Journal:  J Lab Clin Med       Date:  1965-09
View more
  2 in total

Review 1.  alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

2.  The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.

Authors:  Lucinda M Gruber; Sina Jasim; Allison Ducharme-Smith; Toby Weingarten; William F Young; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.